1104P Efficacy of immune checkpoint inhibition in metastatic or non-resectable melanoma after failure of adjuvant anti-PD1 treatment: A EUMelareg real-world evidence study.
Saved in:
| Title: | 1104P Efficacy of immune checkpoint inhibition in metastatic or non-resectable melanoma after failure of adjuvant anti-PD1 treatment: A EUMelareg real-world evidence study. |
|---|---|
| Authors: | Weichenthal, M.1 (AUTHOR), Schadendorf, D.2 (AUTHOR), Bastholt, L.3 (AUTHOR), Gavrilova, I.4 (AUTHOR), Haanen, J.B.A.G.5 (AUTHOR), Mangana, J.6 (AUTHOR), Espinosa, E.7 (AUTHOR), Svane, I-M.8 (AUTHOR), Wouters, M.9 (AUTHOR), Ellebæk, E.10 (AUTHOR), Mohr, P.11 (AUTHOR), Marques Rodas, I.12 (AUTHOR), Asher, N.13 (AUTHOR), Dummer, R.14 (AUTHOR), Gaudy Marqueste, C.15 (AUTHOR), Aya, F.16 (AUTHOR), Gogas, H.17 (AUTHOR), Lebbe, C.18 (AUTHOR), Rutkowski, P.19 (AUTHOR), Ascierto, P.A.20 (AUTHOR) |
| Source: | Annals of Oncology. 2023 Supplement 2, Vol. 34, pS665-S666. 2p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2023.09.2238 |
